Collecting Information About Treatment Results for Patients With Cushing's Syndrome
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT03364803
- Status
- Recruiting
Conditions
- Cushing Disease
- Cushing Syndrome
- Cushing's Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 14 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cushing's QoL (Quality of Life Questionnaire) — OTHERCushing's QoL is a validated disease specific questionnaire consisting of 12 questions on a five-point Likert scale ranging from always to never. The total score ranges from 12 to 60, with a lower score indicating a greater negative impact on health related QoL. This is converted to a 0-100 scale, 0 indicating the worst and 100 indicating the best QoL
- Nottingham Health Profile (NHP) — OTHERNHP is used in patients to assess general health and quality of life. This assessment consists of 38 yes/no questions that are subdivided into six scales assessing impairments: pain (eight items), energy level (three items), sleep (five items), emotional reactions (nine items), social isolation (five items) and physical mobility (eight items). A higher score indicates more impairment
- Hospital Anxiety and Depression Scale (HADS) — OTHERHADS consists of 14 items pertaining to anxiety and depression, with each item measured on a four-point scale. Total scores for the anxiety and depression subscales range from 0 to 21. A higher score indicates greater symptomatology
- Perceived Stress Scale (PSS) — OTHERThe PSS predicts both objective biological markers of stress and increased risk of disease in patients with higher stress levels.
- Barratt's Impulsivity Scale (BIS) — OTHERBDI and BIS in combination have demonstrated that depression and/or binge eating may be mediating factors for the outcome of obesity
- Beck Depression Inventory (BDI) — OTHERBDI and BIS in combination have demonstrated that depression and/or binge eating may be mediating factors for the outcome of obesity
- State-Trait Anxiety Inventory (STAI) — OTHERThe STAI provides data to help distinguish between anxiety and depression.
- State Food Craving Questionnaire-State (FCQ-S) — OTHERThe FCQ-S consists of 15 items assessing: desire to eat, anticipation of positive reinforcement from eating, anticipation of negative reinforcement (reduction of negative affect) from eating, lack of control over eating, and (physiological) hunger; higher scores reflect stronger food craving. Participants respond, using a Likert-type scale, how much each item is true of them right now.
- Trait Food Craving Questionnaire-Trait (FCQ-T) — OTHERTrait food craving will be assessed with the Food Craving Questionnaire-Trait (FCQ-T). The FCQ-T consists of 39 items assessing: intentions/plans to eat, anticipation of positive reinforcement from eating, anticipation of negative reinforcement from eating, lack of control over eating, preoccupation with food, (physiological) hunger, emotions preceding or following food cravings or eating, environmental cues that may elicit food cravings, negative emotions including guilt experienced as a consequence of food cravings, and/or indulging such cravings; higher scores again indicate higher trait craving. Individuals are asked to respond, using a Likert-type scale, how much each item is true of them in general.
- Visual Analogue Scale (VAS) — OTHERA validated visual analogue scale (VAS) questionnaire will be completed in the fasting state. The VAS consists of 100-mm lines with words anchored at each end describing extreme sensations of hunger, prospective consumption ("How much do you think you can eat?"), fullness, and satisfaction, as well as craving (sweet, salty, fatty or savory). Patients will be asked to make a vertical mark across the line corresponding to their feelings. Quantification will performed by measuring the distance from the left end of the line to the mark.
- Sensitivity to Reinforcement of Addictive and other Primary Rewards (STRAP-R) food variant — OTHERA validated questionnaire that assesses perceived subjective value attributed to expected/hypothetical foods and other primary reinforcers will be administered. This variant of this questionnaire was initially developed by Dr. Goldstein to assess 'liking' and 'wanting' of expected drug rewards for patients with cocaine addiction. The current assessment uses a modified version to assess 'liking' and 'wanting' for food.
Study Details
The purpose of this study is to follow participants with Cushing's syndrome during the course of their routine care and to form a data registry to study long term participant outcomes.
Key Dates
- Start date
- Nov 28, 2017
- Status verified
- Oct 2025
- Primary completion
- Nov 28, 2026
- Completion
- Nov 28, 2026
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Participants with Cushing's Syndrome
Primary Outcome Measure
Collection of data on Cushing's Syndrome participants before and over time after surgical, medication, and/or radiation therapy. [ Time Frame: up to 10 years after treatment ]
Central Contacts
- Eliza Geer, MD646-888-2627
- Marc Cohen, MD212-639-3769
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | Eliza Geer, MD 646-888-2627 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | New Jersey | 07748 | Eliza Geer, MD 646-888-2627 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | Eliza Geer, MD 646-888-2627 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) | Commack | New York | 11725 | Eliza Geer, MD 646-888-2627 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | Eliza Geer, MD 646-888-2627 |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Eliza Geer, MD 646-888-2627 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | New York | 11553 | Eliza Geer, MD 646-888-2627 |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center· New York, NY
Related Studies
- An Investigation of Pituitary Tumors and Related Hypothalmic DisordersRecruiting · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Bethesda, Maryland
- Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's SyndromePHASE2 · Recruiting · RECORDATI GROUP · San Francisco, California
- Multicenter Study of Seliciclib (R-roscovitine) for Cushing DiseasePHASE2 · Recruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Long-Term Follow-Up of Survivors of Pediatric Cushing DiseaseRecruiting · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Bethesda, Maryland